Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Company announcement

Article on In Vitro Methods Published in IBI

Wickham Laboratories are excited to announce their most recent publication on “The Importance of Testing for Pyrogens in Raw and In-Process Materials”, written by Section Head of Endotoxin and Cytotoxicity Testing, Sophie Bell.

Read the rest of entry »

Arecor to participate at PepTalk 2019's Protein Science Week in San Diego, CA, USA

Arecor Limited, the UK-based leading formulation technology company,, is pleased to announce its participation at PEPTalk 2019’s Protein Science Week.  This leading international conference and one of the largest annual gatherings of over 1,300 protein science researchers in the world, will be held between January 14-18, 2019, at the Hilton Hotel, San Diego Bayfront, San Diego, California, USA.  

Read the rest of entry »

OBN Appoints New Chairman and Non-Executive Director to Enhance Board Expertise

OBN, the membership organisation supporting the UK’s innovative life sciences companies, announces changes to its Board including the appointment of Bill Fleming as the new Chairman and the appointment of David Browning.

Read the rest of entry »

First production and administration of Axumin® (fluciclovine (18F)) in France

Blue Earth Diagnostics, a leading molecular imaging diagnostics company, yesterday announced that the first commercial production of Axumin® (fluciclovine (18F)) in France occurred recently, with the first French patients being dosed.  Axumin is a novel molecular imaging agent approved in the European Union for use in PET imaging to detect and localize prostate cancer in men experiencing suspected recurrence based on elevated blood prostate specific antigen (PSA) levels after primary curative treatment.

Read the rest of entry »

Arecor to attend the 37th Annual J.P. Morgan Healthcare Conference

Arecor Ltd, the UK-based specialty pharmaceutical company that develops superior biopharmaceuticals through the application of an innovative formulation technology platform, is pleased to announce today that its executive management team, Dr Sarah Howell (Chief Executive Officer) and Dr Jan Jezek (Chief Scientific Officer) will be attending the 37th Annual J.P. Morgan Healthcare Conference, San Francisco, CA.  

Read the rest of entry »

OBN Awards 2018 – Winners Recognised at Industry Leading Event

The OBN Annual Awards celebrates the achievements of the UK life sciences industry.

Read the rest of entry »

Thermo Fisher Scientific brought Science World successfully back to Manchester

Science World, the Fisher Scientific Laboratory Experience, made its successful return to Emirates Old Trafford – Lancashire County Cricket Club, Manchester on 27 September. The event, hosted by Thermo Fisher Scientific, showcased the latest in laboratory innovations available through Fisher Scientific.

Read the rest of entry »

Isansys announces that its advanced wireless patient monitoring platform granted key US patent

Isansys Lifecare, developer of the world’s most advanced real-time patient data collection and analysis platform, has been granted a US patent covering a key feature of its Lifetouch cardiac sensor

Read the rest of entry »

Inivata Achieves Major Milestone with Draft Medicare Local Coverage Determination (LCD) for InVisionFirst™Lung Liquid Biopsy Test

Draft Coverage Supports the Use of InVisionFirst-Lung for Aiding in the Management of Patients with Advanced Non-Small-Cell Lung Cancer . Inivata, a leader in liquid biopsy,  announced on 13 September that Palmetto GBA, a Medicare Administrative Contractor that  evaluates diagnostic technology through its laboratory technology assessment group, MolDx, has published a draft local coverage determination (LCD) for the InVisionFirst-Lung test.

Read the rest of entry »

Arecor secures £6m investment for the clinical development of its diabetes speciality pharma portfolio

On 10 September 2018 Arecor Ltd, the UK-based leader in developing superior biopharmaceuticals through the application of an innovative formulation technology platform, announced that it has secured £6.0 million of investment from new and existing investors for the clinical development of the Company’s speciality pharma portfolio of proprietary diabetes products.

Read the rest of entry »

Pages: Previous1234567...18NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.